Adkins, 2001, Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition, Mol. Pharmacol., 59, 514, 10.1124/mol.59.3.514
Barker, 1996, Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter, Mol. Pharmacol., 50, 957
Blier, 1994, Current advances and trends in the treatment of depression, Trends Pharmacol. Sci., 15, 220, 10.1016/0165-6147(94)90315-8
Kamdar, 2001, Functional role of critical stripe residues in transmembrane span 7 of the serotonin transporter—effects of Na+, Li+, and methanethiosulfonate reagents, J. Biol. Chem., 276, 4038, 10.1074/jbc.M008483200
Kristensen, 2004, Mutational scanning of the human serotonin transporter reveals fast translocating serotonin transporter mutants, Eur. J. Neurosci., 19, 1513, 10.1111/j.1460-9568.2004.03202.x
Plenge, 1985, Antidepressive drugs can change the affinity of [H-3] imipramine and [H-3] paroxetine binding to platelet and neuronal membranes, Eur. J. Pharmacol., 119, 1, 10.1016/0014-2999(85)90314-0
Plenge, 1987, The activity of 25 paroxetine femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants, J. Pharm. Pharmacol., 39, 877, 10.1111/j.2042-7158.1987.tb03121.x
Plenge, 1997, An affinity-modulating site on neuronal monoamine transport proteins, Pharmacol. Toxicol., 80, 197, 10.1111/j.1600-0773.1997.tb00396.x
Plenge, 1991, Affinity modulation of [H-3] imipramine, [H-3] paroxetine and [H-3] citalopram binding to the 5-Ht transporter from brain and platelets, Eur. J. Pharmacol.—Mol. Pharmacol. Sect., 206, 243, 10.1016/S0922-4106(05)80025-2
Roman, 2003, Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis, Eur. J. Pharmacol., 479, 53, 10.1016/j.ejphar.2003.08.056
Rudnick, 1997, Mechanisms of biogenic amine neurotransmitter transporters, 25
Sette, 1983, Complex inhibition of [H-3]imipramine binding by serotonin and nontricyclic serotonin uptake blockers, J. Neurochem., 40, 622, 10.1111/j.1471-4159.1983.tb08026.x
Wennogle, 1982, Serotonin modulates the dissociation of [H-3] imipramine from human-platelet recognition sites, Eur. J. Pharmacol., 86, 303, 10.1016/0014-2999(82)90333-8
Wennogle, 1985, Serotonin uptake inhibitors differentially modulate high-affinity imipramine dissociation in human-platelet membranes, Life Sci., 36, 1541, 10.1016/0024-3205(85)90378-9